← Back to Bain Capital Life Sciences Profile
What is Bain Capital Life Sciences' investment thesis?
Bain Capital Life Sciences is committed to investing in transformative technologies and therapies within the healthcare and life sciences sectors. Their investment approach is grounded in a science-first diligence process, ensuring that each investment has the potential to make a significant impact on patient lives. They seek to build a diverse portfolio of high-impact, high-value-creating companies by adhering to their guiding principles.
Bain Capital Life Sciences, founded in 2016, is a dedicated investment firm focused on driving medical innovation across pharmaceuticals, biotechnology, medical devices, diagnostics, and life science tools. With over $7 billion in assets under management and a team of experts with deep industry and scientific insights, they aim to build a diverse portfolio of high-impact companies addressing unmet medical needs.
- Assets under management: $7 billion+
- Investments globally: 70+
- Medicines or technologies approved or launched: 20+
More Questions About Bain Capital Life Sciences
- What is Bain Capital Life Sciences?
Bain Capital Life Sciences is a dedicated investment firm focused on driving medical innovation across pharmaceuticals, biotechnology, medical devices, diagnostics, and life science tools.
- Where is Bain Capital Life Sciences located?
Bain Capital Life Sciences is located in Boston, United States.
- When was Bain Capital Life Sciences founded?
Bain Capital Life Sciences was founded in 2016.
- What type of investor is Bain Capital Life Sciences?
Bain Capital Life Sciences is a venture capital firm.
- What is the typical check size for Bain Capital Life Sciences?
The typical check size for Bain Capital Life Sciences is $12,500,000 USD.
- Does Bain Capital Life Sciences accept cold outreach?
No, Bain Capital Life Sciences does not accept cold outreach.
Verification Confidence: 92% | Source: investment_thesis | Entity: Bain Capital Life Sciences